Phase 3 study for people with Melanoma

Recruiting Phase 3

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 3
Sponsor Iovance Biotherapeutics, Inc.
Registry number NCT05727904
Started 30 March 2023 Today 16 October 2026 Estimated completion 1 March 2028

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Greenslopes Private Hospital Greenslopes QLD Recruiting
Peter MacCallum Cancer Centre Melbourne VIC Recruiting
Fiona Stanley Hospital Murdoch WA Recruiting
Flinders Medical Centre Bedford Park SA Recruiting
Westmead Hospital Westmead NSW Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 70 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 670

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

1. Participant has a histologically or pathologically confirmed diagnosis of Stage IIIC, IIID, or IV unresectable or metastatic melanoma.

2. In the investigator's assessment, the participant has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 and an estimated life expectancy of \> 6 months.

3. Participant is assessed as having at least one resectable lesion (or aggregate lesions) for lifileucel generation.

4. Participant must have at least one measurable disease as defined by RECIST 1.1 following tumor resection.

5. Participants must have adequate organ function.

6. Participants of childbearing potential or those with partners of childbearing potential must be willing to practice an approved method of highly effective birth control.

7. Participants who are \> 70 years of age may be allowed to enroll after the investigator discusses with the medical monitor.

Exclusion Criteria:

1. Participant has melanoma of uveal/ocular origin.

2. Participant has symptomatic untreated brain metastases.

3. Participant received more than 1 prior line of therapy.

4. Participant received prior therapy for metastatic disease

5. Participants with a BRAF V600 mutation-positive tumor received prior adjuvant/neoadjuvant ICI therapy only

6. Participant has an active medical illness(es) that, in the opinion of the investigator, would pose increased risks for study participation, such as systemic infections; seizure disorders; coagulation disorders; or other active major medical illnesses of the cardiovascular, respiratory, or immune systems.

7. Participant has any form of primary or acquired immunodeficiency (eg, SCID or AIDS).

8. Participant had another primary malignancy within the previous 3 years (except for those that do not require treatment or were curatively treated \>1 year ago, and in the judgment of the investigator do not pose a significant risk of recurrence.)

9. Participant has a history of allogeneic cell or organ transplant.

Other protocol defined inclusion/exclusion criteria could apply.

Dates on the record

Started 30 March 2023
Estimated completion 1 March 2028
Registry last updated 24 September 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 24 September 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.